Given recent findings for the anti-tumor properties of CRF2 agonists [30] and the lack of CRF2 expression on breast cancer cells one may suggest that inhibition of CRF1 and activation of CRF2 may successfully inhibit tumor growth. The gene discussed is CRHR1; the disease is breast cancer.